Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remission.
Journal: International journal of cancer
Published: September 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma.
Journal: Pediatric blood & cancer
Published: March 13, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma.
Journal: Neuro-oncology
Published: February 19, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastoma.
Journal: International journal of cancer
Published: February 18, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes.
Journal: Pediatric blood & cancer
Published: June 09, 2024
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection.
Journal: Journal of imaging informatics in medicine
Published: March 18, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of 124I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 13, 2024
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.
Journal: Research square
Published: March 11, 2024
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.
Journal: EJNMMI research
Published: February 22, 2024
Ovarian function in female survivors of high-risk neuroblastoma.
Journal: Pediatric blood & cancer
Published: January 23, 2024
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience.
Journal: Practical radiation oncology
Published: August 31, 2023
Last Updated: 09/26/2026